Study Detail

CRITERIA

Inclusion Criteria:

• is a healthy South Korean male or female who is 42 to 90 days of age at the time of signing informed consent
• has a parent or legally acceptable representative who understands study procedures, alternative treatments available, and risks involved and voluntarily agrees to participate by signing informed consent

Exclusion Criteria:

• has a history of invasive pneumococcal disease or known history of other culture positive pneumococcal disease
• has known hypersensitivity to pneumococcal conjugate vaccine, any licensed pediatric vaccine to be administered concomitantly, or any diphtheria toxoid-containing vaccine
• has had a recent febrile illness (rectal temperature ≥38.1°C [≥100.5°F] or axillary temperature ≥37.8°C [≥100.0°F]) within 72 hours prior to receipt of study vaccine
• has known or suspected impairment of immunological function
• has or his/her mother has human immunodeficiency virus (HIV) infection
• has or his/her mother has hepatitis B surface antigen-positive test
• has known or history of functional or anatomic asplenia
• has a history of autoimmune disease
• has a history or suspected history of neurological disorder
• has received a pneumococcal vaccine prior to study entry
• has received, or is anticipated to need, corticosteroid therapy
• has received a blood transfusion of immunoglobulin products
• has participated in another clinical study of an investigational product